Addus HomeCare (NASDAQ:ADUS – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report released on Monday.
Several other equities analysts have also recently commented on the company. Truist Financial set a $135.00 target price on Addus HomeCare and gave the company a “buy” rating in a research note on Wednesday, January 7th. Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. BMO Capital Markets began coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective for the company. Finally, Barclays upped their target price on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $135.44.
Check Out Our Latest Analysis on Addus HomeCare
Addus HomeCare Stock Up 0.5%
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. TimesSquare Capital Management LLC lifted its holdings in shares of Addus HomeCare by 6.2% in the third quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after buying an additional 24,301 shares during the period. Russell Investments Group Ltd. raised its position in Addus HomeCare by 10.1% in the second quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock worth $6,439,000 after acquiring an additional 5,110 shares in the last quarter. Creative Planning raised its position in Addus HomeCare by 150.9% in the second quarter. Creative Planning now owns 7,024 shares of the company’s stock worth $809,000 after acquiring an additional 4,224 shares in the last quarter. Public Sector Pension Investment Board lifted its holdings in Addus HomeCare by 14.4% in the 3rd quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock valued at $8,357,000 after acquiring an additional 8,893 shares during the last quarter. Finally, Tributary Capital Management LLC boosted its position in shares of Addus HomeCare by 114.1% during the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock valued at $46,974,000 after purchasing an additional 212,192 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Further Reading
- Five stocks we like better than Addus HomeCare
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
